{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"EP Edge Journal Watch: Cardiac Electrophysiology Research","title":"EP Edge® Journal Watch: Issue 43 November 2026: VT Ablation, Idiopathic VF, His-Bundle Pacing and Endocarditis","html":"","width":"100%","height":180,"duration":1675,"description":"EP Edge® Journal Watch 43 | November 2026: VT Ablation, Idiopathic VF, His-Bundle Pacing and Endocarditis\nHow should we judge new ventricular ablation technologies, reassess survivors of apparently idiopathic ventricular fibrillation, and weigh the long-term consequences of pacing and infection-management decisions?\nIn Issue 43 of EP Edge Journal Watch, Dr. Sharma examines ventricular arrhythmias, cardiac resynchronization, implanted-device safety, and infective endocarditis. Four featured discussions cover CLEAR-VT with its companion device analysis, long-term outcomes after idiopathic ventricular fibrillation, His-Alternative I, and the American Heart Association’s endocarditis scientific statement, including the POET trial.\nShorter reviews address focal pulsed field ablation, arrhythmogenic cardiomyopathy, Brugada syndrome, pacing-induced ventricular dysfunction, device-related infection risk, and cardiovascular nutrition. The episode is designed for cardiac electrophysiologists, cardiologists, fellows, and allied professionals seeking critical appraisal and practical clinical interpretation. Articles are listed below in newsletter order.\nDasa: CLEAR-VT and Dual-Energy Lattice-Tip Ablation of Ventricular Arrhythmias. Featured discussion. Early US experience demonstrates procedural feasibility in a selected, challenging population. We examine acute noninducibility, recurrent ventricular tachycardia, mixed radiofrequency and pulsed field delivery, short follow-up, and complications that limit conclusions about durability and comparative safety. Article DOI. Accompanying Nakamura and Tandri editorial.\nMahmoodi: Effects of Dual-Energy Ventricular Ablation on Cardiac Implantable Electronic Device Performance. Included in the CLEAR-VT feature. This companion analysis examines device interactions and the importance of lead proximity, interrogation, and contingency planning. Overlapping registry patients are not treated as an independent replication of the main study....","thumbnail_url":"https://img.transistorcdn.com/C7iPWVsHlGRm13syn3X4eXGLcqOXyzcuH5XmVutqgHc/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9jMzFi/ZTYxOTI1M2U4NGRj/OGZmZjBhMDFlMjFm/NDQwMC5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}